GALLI, GIULIA
GALLI, GIULIA
Dipartimento di Oncologia ed Emato-Oncologia
THE EUDRACT 2017-004494-13 TRIAL ON THYMIC EPITHELIAL TUMORS: THE PARADIGM OF A COMPREHENSIVE STUDY FOR A RARE DISEASE
2022 G. Galli
SARS-CoV-2 vaccine in patients with thymic epithelial tumours with and without active or pre-existing autoimmune disorders: Brief report of a TYME network safety analysis
2022 F. Giugliano, P.A. Zucali, G. Galli, Z. Ballatore, C. Corti, P.T. Aliaga, J. Uliano, G. Vivanet, G. Curigliano, F. Conforti, P. Queirolo, R. Berardi, S. Manglaviti, G. Apollonio, M. Perrino, F. Borea, F. D'Antonio, M.C. Garassino, T. De Pas
Circulating Fatty Acid Profile as a Biomarker for Immunotherapy in Advanced Non-Small Cell Lung Cancer
2022 G. Galli, P.A. Corsetto, C. Proto, G. Lo Russo, M. Ganzinelli, E. Rulli, L. Legramandi, D. Morelli, R. Ferrara, A. Prelaj, D. Signorelli, A. De Toma, M. Brambilla, M. Occhipinti, S. Manglaviti, M. Boeri, A. Martinetti, A. Vingiani, M.P. Colombo, A.M. Rizzo, V. Torri, F. de Braud, S. Sangaletti, A. Sica, M.C. Garassino
What Matters Most to Lung Cancer Patients? A Qualitative Study in Italy and Belgium to Investigate Patient Preferences
2021 S. Petrocchi, R. Janssens, S. Oliveri, R. Arnou, I. Durosini, P. Guiddi, E. Louis, M. Vandevelde, K. Nackaerts, M.Y. Smith, G. Galli, F. de Marinis, L. Gianoncelli, G. Pravettoni, I. Huys
Patient preferences for lung cancer treatments : A study protocol for a preference survey using discrete choice experiment and swing weighting
2021 D. Monzani, S. Petrocchi, S. Oliveri, J. Veldwijk, R. Janssens, L. Bailo, M.Y. Smith, I. Smith, E. Schoefs, K. Nackaerts, M. Vandevelde, E. Louis, H. Decaluwé, P. De Leyn, H. Declerck, E.G. Katz, F. Petrella, M. Casiraghi, I. Durosini, G. Galli, M.C. Garassino, G.A. de Wit, G. Pravettoni, I. Huys
Beyond LKB1 Mutations in Non-Small Cell Lung Cancer: Defining LKB1less Phenotype to Optimize Patient Selection and Treatment
2020 C. Borzi, G. Galli, M. Ganzinelli, D. Signorelli, C. Vernieri, M.C. Garassino, G. Sozzi, M. Moro
LKB1 mutations are not associated with the efficacy of first-line and second-line chemotherapy in patients with advanced non-small-cell lung cancer (NSCLC): a post hoc analysis of the TAILOR trial
2020 C. Vernieri, M. Ganzinelli, E. Rulli, G. Farina, A.C. Bettini, C. Bareggi, L. Rosso, D. Signorelli, G. Galli, G. Lo Russo, C. Proto, M. Moro, S. Indraccolo, A. Busico, G. Sozzi, V. Torri, M. Marabese, B. Massimo, M.C. Garassino
Accuracy of pathologic diagnosis for thymic epithelial tumors: a brief report from an Italian reference Center
2020 G. Galli, A. Trama, L. Abate-Daga, M. Brambilla, M. Chiara Garassino, A. Fabbri
Choosing wisely first line immunotherapy in non-small cell lung cancer (NSCLC): what to add and what to leave out
2019 C. Proto, R. Ferrara, D. Signorelli, G. Lo Russo, G. Galli, M. Imbimbo, A. Prelaj, N. Zilembo, M. Ganzinelli, L. Pallavicini, I. De Simone, M. Colombo, A. Sicad, V. Torri, M. Garassino
Combination of Immunotherapy and Brain Radiotherapy in Metastatic Melanoma: A Retrospective Analysis
2019 G. Galli, S. Cavalieri, L. Di Guardo, C. Cimminiello, F. Nichetti, F. Corti, M. Garcia, B. Pappalardi, C. Fallai, F. de Braud, M. Platania, M. Del Vecchio
Efficacy and safety of immunotherapy in elderly patients with non-small cell lung cancer
2019 G. Galli, A. De Toma, F. Pagani, G. Randon, B. Trevisan, A. Prelaj, R. Ferrara, C. Proto, D. Signorelli, M. Ganzinelli, N. Zilembo, F. de Braud, M. Garassino, G. Lo Russo
Exploiting FAsting-mimicking Diet and MEtformin to Improve the Efficacy of Platinum-pemetrexed Chemotherapy in Advanced LKB1-inactivated Lung Adenocarcinoma : the FAME Trial
2019 C. Vernieri, D. Signorelli, G. Galli, M. Ganzinelli, M. Moro, A. Fabbri, E. Tamborini, M. Marabese, E. Caiola, M. Broggini, L. Hollander, R. Gallucci, G. Vandoni, C. Gavazzi, T. Triulzi, M.P. Colombo, A.M. Rizzo, P.A. Corsetto, G. Pruneri, F. de Braud, G. Sozzi, V. Torri, M.C. Garassino
Weighing the prognostic role of hyponatremia in hospitalized patients with metastatic solid tumors: the HYPNOSIS study
2019 G. Fucà, L. Mariani, S. Lo Vullo, G. Galli, R. Berardi, M. Di Nicola, C. Vernieri, D. Morelli, K. Dotti, I. Fiordoliva, S. Rinaldi, C. Gavazzi, F. Pietrantonio, M. Platania, F. de Braud
Modulation of peripheral blood immune cells by early use of steroids and its association with clinical outcomes in patients with metastatic non-small cell lung cancer treated with immune checkpoint inhibitors
2019 G. Fucà, G. Galli, M. Poggi, G. Lo Russo, C. Proto, M. Imbimbo, R. Ferrara, N. Zilembo, M. Ganzinelli, A. Sica, V. Torri, M. Colombo, C. Vernieri, A. Balsari, F. de Braud, M. Garassino, D. Signorelli
Association between Antibiotic-Immunotherapy Exposure Ratio and outcome in metastatic Non Small Cell Lung Cancer
2019 G. Galli, T. Triulzi, C. Proto, D. Signorelli, M. Imbimbo, M. Poggi, G. Fucà, M. Ganzinelli, M. Vitali, D. Palmieri, A. Tessari, F. de Braud, M. Garassino, M. Colombo, G. Lo Russo
Single Institution trial of anthracycline- and taxane-based chemotherapy for operable breast cancer: The ASTER study
2019 G. Mariani, G. Galli, S. Cavalieri, P. Valagussa, G. Bianchi, G. Capri, S. Cresta, L. Ferrari, S. Damian, M. Duca, F. de Braud, A. Moliterni
Unusual skin toxicity associated with sustained disease response induced by nivolumab in a patient with non-small cell lung cancer
2019 G. Galli, C. Proto, M. Cossa, B. Valeri, S. Sdao, D. Signorelli, M. Imbimbo, F. de Braud, M. Garassino, G. Lo Russo
Metformin plus /- cyclic fasting mimicking diet in combination with platinum-pemetrexed chemotherapy for advanced LKB1 inactive lung adenocarcinoma : The FAME trial
2019 G. Galli, D. Signorelli, C. Vernieri, M. Ganzinelli, M. Moro, A. Fabbri, E. Tamborini, M. Marabese, E. Caiola, M. Broggini, L. Hollander, R. Gallucci, C. Gavazzi, A.M. Rizzo, P. Corsetto, G. Pruneri, F. de Braud, G. Sozzi, V. Torri, M.C. Garassino
Uncommon mutations in epidermal growth factor receptor and response to first and second generation tyrosine kinase inhibitors : a case series and literature review
2018 G. Galli, G. Corrao, M. Imbimbo, C. Proto, D. Signorelli, M. Ganzinelli, N. Zilembo, M. Vitali, F. de Braud, M.C. Garassino, G. Lo Russo
Clinical implications for pro-GRP in small cell lung cancer. A single center experience
2018 S. Cavalieri, D. Morelli, A. Martinetti, G. Galli, F. Nichetti, F.G.M. DE BRAUD, M. Platania